European Archives - Page 1141 of 1191 - European Medical Journal

EMJ

New drugs in neoadjuvant breast cancer therapy

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Sibylle Loibl (German Breast Group, Neu-Isenburg, Germany) discusses recent…

EMJ

Are randomised trials obsolete or more important than ever?

At the 14th St. Gallen International Breast Cancer Conference (SG-BCC) 2015, Dr Clifford Hudis (Memorial Sloan Kettering Cancer Center, New York, NY) Dr…

EMJ

Saunas Take the Heat Off Heart Disease

MEN who regularly use a sauna have a significantly lower risk of cardiovascular (CV) and all-cause mortality than those who attend less frequently.

EMJ

Fondaparinux the Best Option to Tackle NSTEMI?

DEATH and in-hospital bleeding in patients with non-ST-segment elevation myocardial infarction (NSTEMI) appears less likely through the use of…

EMJ

One in Four Advanced Lung Cancer Patients Tested for EGFR Mutations Started on First-Line Treatment Before Test Results Available

Geneva, Switzerland, 17 April 2015 — Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving…

EMJ

Smokers Underestimate Risks of a Few Cigarettes

Geneva, Switzerland, 17 April 2015 — Many people still dangerously underestimate the health risks associated with smoking even a few cigarettes a day…

EMJ

NITID – Innovation in Skin Imaging Presented in Vienna

Madrid, April 16, 2015. DermaLumics presents NITID*, an innovative, non-invasive diagnosis tool for skin surface using Optical Coherence Tomography (OCT)…

EMJ

Evidence Grows That Melanoma Drugs Benefit Some Lung Cancer Patients

Geneva, Switzerland, 17 April 2015 — A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to…

EMJ

New Real-World Clinical Practice Study Highlights the Value of the Oncotype DX® Breast Cancer Test for Patients, Physicians and the Health Care System

Studies present results from a real-life observational study in Ireland demonstrating significant reductions in chemotherapy and resulting cost-savings when the test is used in early stage breast cancer.

The Liver Meeting 2014

Rapid developments in clinical research on the hepatitis C virus infection in the last few years have led to the development of direct-acting…